Adicet Bio, Inc.
ACET · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $25 | $10 |
| % Growth | – | -100% | 156.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $25 | $10 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $99 | $106 | $71 | $49 |
| G&A Expenses | $28 | $27 | $26 | $22 |
| SG&A Expenses | $28 | $27 | $26 | $22 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $19 | $0 | $0 |
| Operating Expenses | $128 | $152 | $98 | $71 |
| Operating Income | -$128 | -$152 | -$73 | -$61 |
| % Margin | – | – | -290.3% | -631.4% |
| Other Income/Exp. Net | $10 | $9 | $3 | -$1 |
| Pre-Tax Income | -$117 | -$143 | -$70 | -$62 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$117 | -$143 | -$70 | -$62 |
| % Margin | – | – | -279.3% | -637.2% |
| EPS | -1.33 | -3.31 | -1.7 | -2 |
| % Growth | 59.8% | -94.7% | 15% | – |
| EPS Diluted | -1.33 | -3.31 | -1.7 | -2 |
| Weighted Avg Shares Out | 88 | 43 | 41 | 31 |
| Weighted Avg Shares Out Dil | 88 | 43 | 41 | 31 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $10 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $6 | $5 | $2 |
| EBITDA | -$111 | -$137 | -$65 | -$60 |
| % Margin | – | – | -258.9% | -620.9% |